Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZSCAN5A antisense RNA 1 (ZSCAN5A-AS1) is a human long non-coding RNA gene located on chromosome 19 (19q13), transcribed from the opposite strand to the ZSCAN5A gene. It is part of the lncRNA class, meaning it does not encode a protein product, and it is presumed to be involved in regulatory RNA processes that may affect the expression of the nearby ZSCAN5A protein-coding gene, which encodes a putative transcription factor. However, the explicit function, disease association, and mechanisms specific to ZSCAN5A-AS1 are not established in current reference sources, nor is it established as a therapeutic target or clinically actionable biomarker.
No drugs or agents reported to act on or through ZSCAN5A-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZSCAN5A antisense RNA 1 (ZSCAN5A-AS1).